Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEDFAR is a private Canadian health technology company that develops and commercializes cloud-based electronic medical record and integrated care software for physicians, care teams, clinics, and patients. Its flagship product, MYLE, is a web-based EMR and care platform used in primary care and clinic workflows, with related capabilities spanning patient engagement, interoperability, analytics, laboratory information support, and revenue cycle management. The company was founded in 2010 and has grown from its Quebec EMR base into broader North American healthcare software through organic expansion and acquisitions. MEDFAR is not a drug developer; it is a commercial-stage healthcare software vendor focused on digitizing ambulatory and primary care operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEDFAR Clinical Solutions.